Froelich, M.F.; Schnitzer, M.L.; Holzgreve, A.; Gassert, F.G.; Gresser, E.; Overhoff, D.; Schwarze, V.; Fabritius, M.P.; Nörenberg, D.; von Münchhausen, N.;
et al. Cost-Effectiveness Analysis of 68Ga DOTA-TATE PET/CT, 111In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors. Diagnostics 2021, 11, 334.
https://doi.org/10.3390/diagnostics11020334
AMA Style
Froelich MF, Schnitzer ML, Holzgreve A, Gassert FG, Gresser E, Overhoff D, Schwarze V, Fabritius MP, Nörenberg D, von Münchhausen N,
et al. Cost-Effectiveness Analysis of 68Ga DOTA-TATE PET/CT, 111In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors. Diagnostics. 2021; 11(2):334.
https://doi.org/10.3390/diagnostics11020334
Chicago/Turabian Style
Froelich, Matthias Frank, Moritz Ludwig Schnitzer, Adrien Holzgreve, Felix Gerhard Gassert, Eva Gresser, Daniel Overhoff, Vincent Schwarze, Matthias Philipp Fabritius, Dominik Nörenberg, Niklas von Münchhausen,
and et al. 2021. "Cost-Effectiveness Analysis of 68Ga DOTA-TATE PET/CT, 111In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors" Diagnostics 11, no. 2: 334.
https://doi.org/10.3390/diagnostics11020334
APA Style
Froelich, M. F., Schnitzer, M. L., Holzgreve, A., Gassert, F. G., Gresser, E., Overhoff, D., Schwarze, V., Fabritius, M. P., Nörenberg, D., von Münchhausen, N., Hokamp, N. G., Auernhammer, C. J., Ilhan, H., Todica, A., & Rübenthaler, J.
(2021). Cost-Effectiveness Analysis of 68Ga DOTA-TATE PET/CT, 111In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors. Diagnostics, 11(2), 334.
https://doi.org/10.3390/diagnostics11020334